Moreover, miR-495-3p regulates the proliferation, migration and apoptosis of CRC cells by targeting HMGB1 in vivo and in vitro, revealing the expectation that miR-495-3p could be used as a potential therapeutic target for CRC. This evidence concerns the gene HMGB1 and colorectal carcinoma.